News

12/20/2012 - Lanx Launches Patient Education Website on Minimally Invasive Spinal Fusion


Read More »

10/11/2012 - Lanx, Inc. Announces Improved Patient Outcomes Data and Reduced Hospital Costs with ASPEN™ MIS Fusion System


Read More »

10/02/2012 - EndoGastric Solutions Completes Patient Enrollment in Clinical Trial Comparing TIF® Procedure to PPI Therapy for the Treatment of GERD


Read More »

09/18/2012 - Aptus Endosystems Receives U.S. FDA Clearance for Thoracic-Length HeliFX™ Aortic Securement System


Read More »

09/17/2012 - Lanx, Inc. Announces New Clinical Data That Show 94% Fusion Rate with ASPEN™ MIS Fusion System


Read More »

09/06/2012 - 10,000th Patient in the United States Treated with Transoral Incisionless Fundoplication (TIF®) Using EsophyX® Technology from EndoGastric Solutions


Read More »

08/14/2012 - Lanx, Inc. Announces U.S. Patent Granted for ASPEN™ MIS Fusion System


Read More »

07/02/2012 - Argos Therapeutics Receives FDA Approval of Special Protocol Assessment for AGS-003 Phase 3 Trial


Read More »

06/28/2012 - EndoGastric Solutions Announces Second Randomized Controlled Trial Comparing TIF Procedure to PPI Therapy for the Treatment of GERD


Read More »

06/27/2012 - Aptus Endosystems Completes $25 Million Series BB Financing


Read More »

06/21/2012 - EndoGastric Solutions Raises $13 Million in Additional Funding


Read More »

06/15/2012 - ViaCyte Appoints Dr. Paul Laikind Chief Executive Officer


Read More »

06/11/2012 - Achillion Appoints Kurt Graves to Its Board of Directors


Read More »

06/07/2012 - Argos Therapeutics Presents Positive Phase 1a Data for AGS-009 in Patients with Lupus at 2012 EULAR Congress


Read More »

06/06/2012 - Achillion Announces Resignation of Chief Medical Officer


Read More »

05/21/2012 - Achillion Announces Additional Proof-of-Concept Data With ACH-2684 for the Treatment of Hepatitis C


Read More »